Quinoline and thiazolopyridine allosteric inhibitors of MALT1

被引：13

作者：

Scott, David A. ^{[1
,2
]}

Hatcher, John M. ^{[1
,2
]}

Liu, Hongyan ^{[5
]}

Fu, Mingpeng ^{[5
]}

Du, Guangyan ^{[1
,2
]}

Fontan, Lorena ^{[3
]}

Us, Ilkay ^{[3
]}

Casalena, Gabriella ^{[3
]}

Qiao, Qi ^{[4
]}

Wu, Hao ^{[4
]}

Melnick, Ari ^{[3
]}

Gray, Nathanael S. ^{[1
,2
]}

机构：

[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA

[2] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 360 Longwood Ave, Boston, MA 02115 USA

[3] Cornell Univ, Div Hematol & Oncol, Dept Med, Weill Cornell Med, New York, NY 10021 USA

[4] Harvard Med Sch, Program Cellular & Mol Med, Boston Childrens Hosp, Boston, MA 02115 USA

[5] PepTech Shanghai Pharmaceut Corp, 388 Yindu Rd, Shanghai 200231, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 14期

关键词：

MALT1; Protease inhibitors; Allosteric; B-cell lymphomas; PROTEASE;

D O I：

10.1016/j.bmcl.2019.05.040

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Quinolines and thiazolopyridines were developed as allosteric inhibitors of MALT1, with good cellular potency and exquisite selectivity. Mouse pharmacokinetic (PK) profiling showed these to have low in vivo clearance, and moderate oral exposure. The thiazolopyridines were less lipophilic than the quinolines, and one thiazolopyridine example was active in our hIL10 mouse pharmacodynamic (PD) model upon oral dosing.

引用

页码：1694 / 1698

页数：5

共 50 条

[1] In silico study on identification of novel MALT1 allosteric inhibitors
Zhang, Jinrui
Ren, Li
Wang, Ye
Fang, Xuexun
RSC ADVANCES, 2019, 9 (67) : 39338 - 39347
[2] Structural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 Paracaspase
Schlauderer, Florian
Lammens, Katja
Nagel, Daniel
Vincendeau, Michelle
Eitelhuber, Andrea C.
Verhelst, Steven H. L.
Kling, Dale
Chrusciel, Al
Ruland, Juergen
Krappmann, Daniel
Hopfner, Karl-Peter
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (39) : 10384 - 10387
[3] Discovery and optimization of cyclohexane-1,4-diamines as allosteric MALT1 inhibitors
Schiesser, Stefan
Hajek, Peter
Pople, Huw E.
Kack, Helena
Oster, Linda
Cox, Rhona J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 227
[4] Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease
Lu, Tianbao
Connolly, Peter J.
Philippar, Ulrike
Sun, Weimei
Cummings, Maxwell D.
Barbay, Kent
Gys, Luc
Van Nuffel, Luc
Austin, Nigel
Bekkers, Mariette
Shen, Fang
Cai, Ann
Attar, Ricardo
Meerpoel, Lieven
Edwards, James
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (23)
[5] A New "Brew" of MALT1 Inhibitors
Young, Ryan M.
Staudt, Louis M.
CANCER CELL, 2012, 22 (06) : 706 - 707
[6] Pyrazolopyrimidines as novel selective allosteric MALT1 inhibitors with in vivo activity in ABC-DLBCL
Weiss, Andreas
Radimerski, Thomas
Wyss, Daniel
Andraos, Rita
Buhles, Alexandra
Sterker, Dario
Quancard, Jean
Pissot, Carole
Simic, Oliver
Bigaud, Marc
Bornancin, Frederic
Schlapbach, Achim
Regnier, Catherine
McSheehy, Paul
Buchdunger, Elisabeth
Wartmann, Markus
Renatus, Martin
Endres, Ralf
Sellers, William
Hofmann, Francesco
CANCER RESEARCH, 2018, 78 (13)
[7] Development of new Malt1 inhibitors and probes
Xin, Bo-Tao
Schimmack, Gisela
Du, Yimeng
Florea, Bogdan I.
van der Marel, Gijsbert A.
Driessen, Christoph
Krappmann, Daniel
Overkleeft, Herman S.
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (15) : 3312 - 3329
[8] Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing
Soldermann, Carole Pissot
Simic, Oliver
Renatus, Martin
Erbel, Paulus
Melkko, Samu
Wartmann, Markus
Bigaud, Marc
Weiss, Andreas
McSheehy, Paul
Endres, Ralf
Santos, Paulo
Blank, Jutta
Schuffenhauer, Ansgar
Bold, Guido
Buschmann, Nicole
Zoller, Thomas
Altmann, Eva
Manley, Paul W.
Dix, Ina
Buchdunger, Elisabeth
Scesa, Julien
Quancard, Jean
Schlapbach, Achim
Bornancin, Frederic
Radimerski, Thomas
Regnier, Catherine H.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 14576 - 14593
[9] MALT1 Inhibitors for Treating Cancer and Immunological Diseases
Sabnis, Ram W.
ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (09): : 1419 - 1420
[10] MALT1 and the MALT1/API2 fusion gene in MALT lymphoma
Borowsky, AD
Gao, WW
Sklar, J
MODERN PATHOLOGY, 2001, 14 (01) : 156A - 156A

← 1 2 3 4 5 →